If a doctor suspects that a person does not have a healthy amount of iron in their blood, they may
Continue reading »
ALEX trial results show alectinib further outpacing crizotinib in ALK+ NSCLC
Updated results of the global phase III ALEX trial comparing alectinib with crizotinib as first-line treatment against ALK-positive non-small cell
Continue reading »
Biotin supplements caused misleading test results, almost led to unnecessary procedure
A new case report in the Journal of the Endocrine Society documents how a patient’s use of a common biotin
Continue reading »